Kelly Scientific – Cutting Edge Market Intelligence
USA/Canada Toll Free
Rest of World
Granulocyte Colony-Stimulating Factor (G-CSF)
Showing all 1 result
Sort by popularity
Sort by average rating
Sort by latest
Sort by price: low to high
Sort by price: high to low
Global & USA BioSimilar Market Analysis to 2021
Tweets by @KellySciPub
Mvasi by Amgen is the First FDA Approved Cancer Biosimilar
Kelly Scientific Winner of Network Kildare Business Award
Regenerative Medicine Market to Hit $53 billion by 2021 – How Will the Trump Administration Impact its Growth?
Regenerative Medicine Market to Hit $53 billion by 2021 – How Will the Trump Administration Affect its Growth?
What Do Investors Want from Cell & Gene Therapy Companies?